I cherish our values and best-in-class governance, which together have enabled Takeda to become the global, values-based, R&D-driven biopharmaceutical leader it is today.
Our set of values is Takeda-ism (Integrity, Fairness, Honesty, and Perseverance) and our priorities (Patient-Trust-Reputation-Business). Takeda-ism has remained strong and steady since our origin in Japan in 1781. It ensures that we always do the right thing for Patients, reinforce Trust with society, improve our company Reputation, and develop our Business (in that order). Takeda-ism and our priorities together form the compass that guides our boundless journey towards Better Health and a Brighter Future for people worldwide through leading innovation in medicine.
As we discover and develop life-saving or life-transforming medicines, we take very seriously our responsibility to improve human health for all. Our patients trust us with their health, and so we must act with the Patient and Trust in mind. At Takeda, we strive to live up to – and exceed – those high expectations.
The Takeda Executive Team (TET) consists of an experienced and diverse group of 19 leaders. Each team member brings a unique perspective to the table, with the team – and our company – made stronger by its diversity in terms of gender, experience, geography, and 10 different nationalities. TET members manage and supervise each function of the Takeda Group, including key committees responsible for matters related to general management, products and R&D, and risk management. This diversity of our leadership is a strength that drives our innovation, agility, and connectivity with an ever-evolving society, forging our path toward our company's future success.
Takeda’s Board of Directors holds me accountable for ensuring that all our decisions and actions are in the best interests of all stakeholders and aligned with our values. With 12 of our 16 Board members serving as External Directors, we guarantee our transparency and objectivity to represent those stakeholders. In addition, the independence of the Board of Directors has been strengthened by having an External Director serve as Chair of the Board of Directors. Furthermore, all three major governance committees (Audit and Supervisory Committee, Compensation Committee, and Nomination Committee) are chaired by External Directors, and all members of the committeesare composed of External Directors. Our advanced and robust corporate governance model has been, and will continue to be, critical to Takeda's success.
As we are now entering into a new phase of Takeda’s development, our values and heritage inspire us to improve more lives in the future, as a truly global biopharmaceutical leader with an unwavering commitment to patients. For generations to come, our commitment to realizing Better Health and a Brighter Future for all – and doing so with the utmost integrity – will remain steadfast.